Page last updated: 2024-10-25

clomipramine and Dystonic Disorders

clomipramine has been researched along with Dystonic Disorders in 1 studies

Clomipramine: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.
clomipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.

Dystonic Disorders: Acquired and inherited conditions that feature DYSTONIA as a primary manifestation of disease. These disorders are generally divided into generalized dystonias (e.g., dystonia musculorum deformans) and focal dystonias (e.g., writer's cramp). They are also classified by patterns of inheritance and by age of onset.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duggal, HS1
Dutta, S1
Sinha, VK1

Other Studies

1 other study available for clomipramine and Dystonic Disorders

ArticleYear
Clomipramine discontinuation-emergent dystonia.
    The Australian and New Zealand journal of psychiatry, 2001, Volume: 35, Issue:5

    Topics: Acute Disease; Adult; Antidepressive Agents, Tricyclic; Clomipramine; Dystonic Disorders; Humans; Ma

2001